294 related articles for article (PubMed ID: 34488905)
1. The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy.
Wang Z; Zhao T; Zhang S; Wang J; Chen Y; Zhao H; Yang Y; Shi S; Chen Q; Liu K
Biomark Res; 2021 Sep; 9(1):68. PubMed ID: 34488905
[TBL] [Abstract][Full Text] [Related]
2. The role of Wnt/β-catenin signaling pathway in the pathogenesis and treatment of multiple myeloma (review).
Yuan Y; Guo M; Gu C; Yang Y
Am J Transl Res; 2021; 13(9):9932-9949. PubMed ID: 34650674
[TBL] [Abstract][Full Text] [Related]
3. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis.
Lee SK; Hwang JH; Choi KY
Adv Biol Regul; 2018 May; 68():46-54. PubMed ID: 29449169
[TBL] [Abstract][Full Text] [Related]
5. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
Yan M; Li G; An J
Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
[TBL] [Abstract][Full Text] [Related]
6. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
7. [T Cell Factor 4, beta-catenin and SFRP1 Expression of Wnt Signaling Pathway in Colorectal Carcinoma and the Prognosis].
Ou Y; Jing G; Liu J; Gao S; Cheng Z; Dong X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Aug; 32(4):854-61. PubMed ID: 26710459
[TBL] [Abstract][Full Text] [Related]
8. Wnt/beta-catenin signaling pathway as a novel cancer drug target.
Luu HH; Zhang R; Haydon RC; Rayburn E; Kang Q; Si W; Park JK; Wang H; Peng Y; Jiang W; He TC
Curr Cancer Drug Targets; 2004 Dec; 4(8):653-71. PubMed ID: 15578921
[TBL] [Abstract][Full Text] [Related]
9. UHRF2 promotes intestinal tumorigenesis through stabilization of TCF4 mediated Wnt/β-catenin signaling.
Li L; Duan Q; Zeng Z; Zhao J; Lu J; Sun J; Zhang J; Siwko S; Wong J; Shi T; Zhang X; Liu M; Chen J; Li D
Int J Cancer; 2020 Oct; 147(8):2239-2252. PubMed ID: 32372448
[TBL] [Abstract][Full Text] [Related]
10. E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling.
Dominguez-Brauer C; Khatun R; Elia AJ; Thu KL; Ramachandran P; Baniasadi SP; Hao Z; Jones LD; Haight J; Sheng Y; Mak TW
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1148-E1157. PubMed ID: 28137882
[TBL] [Abstract][Full Text] [Related]
11. The stress response gene ATF3 is a direct target of the Wnt/β-catenin pathway and inhibits the invasion and migration of HCT116 human colorectal cancer cells.
Inoue M; Uchida Y; Edagawa M; Hirata M; Mitamura J; Miyamoto D; Taketani K; Sekine S; Kawauchi J; Kitajima S
PLoS One; 2018; 13(7):e0194160. PubMed ID: 29966001
[TBL] [Abstract][Full Text] [Related]
12. The Wnt/β-catenin and PI3K/Akt signaling pathways promote EMT in gastric cancer by epigenetic regulation via H3 lysine 27 acetylation.
Song Y; Li ZX; Liu X; Wang R; Li LW; Zhang Q
Tumour Biol; 2017 Jul; 39(7):1010428317712617. PubMed ID: 28671020
[TBL] [Abstract][Full Text] [Related]
13. Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.
Chen J; Rajasekaran M; Hui KM
Exp Biol Med (Maywood); 2017 Jun; 242(11):1142-1149. PubMed ID: 28429652
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis.
Li SS; Sun Q; Hua MR; Suo P; Chen JR; Yu XY; Zhao YY
Front Pharmacol; 2021; 12():719880. PubMed ID: 34483931
[TBL] [Abstract][Full Text] [Related]
15. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
Song L; Li Y; He B; Gong Y
Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
[TBL] [Abstract][Full Text] [Related]
16. Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights.
Patel S; Alam A; Pant R; Chattopadhyay S
Front Immunol; 2019; 10():2872. PubMed ID: 31921137
[TBL] [Abstract][Full Text] [Related]
17. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
18. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
Prosperi JR; Goss KH
Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
Masuda M; Sawa M; Yamada T
Pharmacol Ther; 2015 Dec; 156():1-9. PubMed ID: 26542362
[TBL] [Abstract][Full Text] [Related]
20. Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling.
Ahmad R; Kumar B; Chen Z; Chen X; Müller D; Lele SM; Washington MK; Batra SK; Dhawan P; Singh AB
Oncogene; 2017 Nov; 36(47):6592-6604. PubMed ID: 28783170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
